<DOC>
	<DOCNO>NCT01346072</DOCNO>
	<brief_summary>This study investigate association level peptide copeptin response tolvaptan , drug block action water retain hormone vasopressin .</brief_summary>
	<brief_title>Pilot Study Using Copeptin Predict Response Tolvaptan</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Tolvaptan</mesh_term>
	<criteria>1 . Male female patient history chronic symptomatic heart failure , define dyspnea exertion edema , due cardiac dysfunction , least one month 's duration 2 . Left ventricular ejection fraction â‰¤ 45 % documented quantitative assessment accept imaging technique within one year screen 3 . Meet baseline copeptin criterion entry 4 . Currently take diuretic ( diuretic define loop thiazide diuretic aldosterone antagonist dose ) 1 . Current New York Heart Association Functional Class IV heart failure 2 . Patients felt volume deplete base clinical examination need reduce diuretic administration 3 . Presence clinical contraindication tolvaptan 4 . Episode acute myocardial infarction acute coronary syndrome within past 3 month 5 . Cardiovascular surgical procedure within past 4 week 6 . CHF due uncorrected thyroid disease , active myocarditis , know amyloid cardiomyopathy . 7 . History primary significant liver disease acute hepatic failure , define investigator . 8 . Chronic uncontrolled diabetes mellitus determine investigator . 9 . Supine systolic arterial blood pressure &lt; 90 mmHg screen 10 . Serum creatinine &gt; 3.5 mg/dL screen 11 . Serum potassium &gt; 5.5 mEq/L &lt; 3.5 mEq/L screen 12 . Subjects currently treat hemofiltration dialysis j . Subjects judge investigator unable maintain accurate intake output hospitalization relate medical problem</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>tolvaptan</keyword>
	<keyword>copeptin</keyword>
	<keyword>heart failure</keyword>
	<keyword>vasopressin antagonist</keyword>
</DOC>